Back

Tricuspid regurgitation in patients undergoing mitral valve surgery for primary mitral regurgitation

18 May 2025 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Cutting edge transcatheter heart failure therapeutics Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Klara Lodin

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Risk assessment in patients with low-flow, low-gradient aortic stenosis undergoing TAVI
Doctor M. Caetano Coelho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of treatment modality on prognostic features in patients with severe tricuspid regurgitation
Doctor K. Kresoja (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes of mitral transcatheter edge-to-edge repair in patients with heart failure and functional mitral regurgitation from the MiCLASP Study
Doctor K. Rommel (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Impact of ejection fraction based heart failure classification on TAVI related outcomes
Doctor Y. Sener (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
De novo conduction disturbances after TAVI: what to expect?
Doctor D. Da Silva Correia (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cutting edge transcatheter heart failure therapeutics

The Event

Event poster

Heart Failure 2025

18 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Tricuspid regurgitation in patients undergoing mitral valve surgery for primary mitral regurgitation
thumbnail
Congress Presentation
Development of tricuspid regurgitation after left-side heart surgery
thumbnail
Congress Session
Tricuspid valve intervention: ready for prime time?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources